In the presence of Minister of Health Dao Hong Lan, Deputy Minister of Science and Technology Le Xuan Dinh, Deputy Minister of Foreign Affairs Dang Hoang Giang, and representatives of relevant government agencies, MSD and the Vietnam Vaccine Joint Stock Company (VNVC) announced a plan to collaborate on the technology transfer, manufacturing, and localization of strategic vaccine technology products.
The announcement marks a key milestone during the visit of MSD’s
senior leadership team to Vietnam, laying the groundwork for further steps
toward the long-term transfer of scientific knowledge, technical expertise,
quality processes, and manufacturing capabilities to VNVC. The ceremony brought
together Dr. Marc Gailhardou, President of MSD’s Intercontinental Region; Dr.
Andrew Otoo, President of MSD in Asia Pacific, Mr. Ngo Chi Dung, VNVC’s
Chairman and CEO, and other key stakeholders.
“MSD looks forward to
bringing more than 130 years of global expertise to this planned partnership,”
said Dr. Gailhardou. “We are equally encouraged by VNVC’s local leadership,
investment, and long-term vision. By combining our respective strengths, we hope
to support stronger disease prevention efforts and deliver lasting benefits for
the health of the Vietnamese people.”
Mr. Dung said VNVC has worked closely with MSD for many years to bring millions of vaccine doses to people in Vietnam each year. Building on this successful collaboration, the two parties are working toward a strategic cooperation plan covering technology transfer, manufacturing, and localization of strategic vaccine technology product, contributing to Vietnam’s vision of advancing science and technology and strengthening healthcare self-reliance.
“VNVC views high-tech vaccine manufacturing a long-term strategy that requires significant investment in technology, human resources, and quality management,” he continued. “We have invested in the development of a modern manufacturing facility and are building the foundation to receive and progressively master advanced technologies. Our plan to collaborate with MSD marks an important step forward, opening opportunities to access world-leading vaccine manufacturing technologies, strengthen domestic supply capabilities, expand access to vaccines, and enhance Vietnam’s position in the global vaccine industry.”
Later that day, MSD leaders met with Deputy Prime Minister Pham Thi Thanh Tra, where discussions focused on Vietnam’s healthcare priorities, the role of science, technology, and innovation in advancing healthcare, and opportunities to strengthen collaboration between the government and the private sector. During the meeting, MSD shared details of its plan to collaborate with VNVC on the technology transfer, manufacturing, and localization of strategic vaccine technology products, reflecting its long-term commitment to Vietnam. The parties also explored ways to expand access to innovative medicines and high-quality vaccines while contributing to a more sustainable healthcare system.
MSD’s planned partnership with VNVC, together with its high-level engagements during the visit, reinforces the role of partnership, science, and innovation in supporting the sustainable development of Vietnam’s healthcare system.
Google translate